{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-25-037598","form_type":"8-K","ticker":"AHCO","cik":"0001725255","company_name":"AdaptHealth Corp.","filed_at":"2025-08-05T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.808805+00:00","generated_at":"2026-05-17T20:51:18.332024+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"AdaptHealth Q2 2025 revenue $800.4M, net income $14.7M; lowers FY adjusted EBITDA guidance","bullets":["Net revenue $800.4M, down 0.7% YoY; net income $14.7M vs $19.4M in prior year.","Adjusted EBITDA $155.5M, down 5.9% YoY; year-to-date cash flow from ops $257.5M.","FY 2025 revenue guidance narrowed to $3.18B-$3.26B; adjusted EBITDA lowered to $642M-$682M.","Closed sales of certain incontinence and infusion assets in Wellness at Home segment.","Announces new capitated partnership with a major national healthcare system (no details)."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-25-037598","json":"https://secwatch.observer/filing/0001628280-25-037598.json","markdown":"https://secwatch.observer/filing/0001628280-25-037598.md","text":"https://secwatch.observer/filing/0001628280-25-037598.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1725255/000162828025037598/0001628280-25-037598-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1725255/000162828025037598/ahco-20250805.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T20:51:18.332024+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}